about
Oral insulin delivery: how far are we?Neuroprotective Activity of Hypericum perforatum and Its Major ComponentsThe potential of HIV-1 nanotherapeutics: from in vitro studies to clinical trialsProbing insulin bioactivity in oral nanoparticles produced by ultrasonication-assisted emulsification/internal gelation.Co-encapsulation of lyoprotectants improves the stability of protein-loaded PLGA nanoparticles upon lyophilization.Nanotechnology-based systems for the treatment and prevention of HIV/AIDS.Effect of the Freezing Step in the Stability and Bioactivity of Protein-Loaded PLGA Nanoparticles Upon Lyophilization.Synthesis and characterization of 3,6-O,O'- dimyristoyl chitosan micelles for oral delivery of paclitaxel.Development and validation of a rapid reversed-phase HPLC method for the determination of insulin from nanoparticulate systems.Shedding light on the puzzle of drug-membrane interactions: Experimental techniques and molecular dynamics simulations.Validation of a high-performance liquid chromatography method for the determination of (-)-alpha-bisabolol from particulate systems.Mad2 checkpoint gene silencing using epidermal growth factor receptor-targeted chitosan nanoparticles in non-small cell lung cancer model.Co-association of methotrexate and SPIONs into anti-CD64 antibody-conjugated PLGA nanoparticles for theranostic application.Natural extracts into chitosan nanocarriers for rosmarinic acid drug delivery.Combinatorial-Designed Epidermal Growth Factor Receptor-Targeted Chitosan Nanoparticles for Encapsulation and Delivery of Lipid-Modified Platinum Derivatives in Wild-Type and Resistant Non-Small-Cell Lung Cancer Cells.Amorphous solid dispersions: Rational selection of a manufacturing process.Safety profile of solid lipid nanoparticles loaded with rosmarinic acid for oral use: in vitro and animal approachesCurcumin Encapsulated into Methoxy Poly(Ethylene Glycol) Poly(ε-Caprolactone) Nanoparticles Increases Cellular Uptake and Neuroprotective Effect in Glioma Cells.In vitro evaluation of biodegradable lignin-based nanoparticles for drug delivery and enhanced antiproliferation effect in cancer cells.The biopharmaceutical classification system of excipients.Design and statistical modeling of mannose-decorated dapsone-containing nanoparticles as a strategy of targeting intestinal M-cells.Biodistribution and pharmacokinetics of Mad2 siRNA-loaded EGFR-targeted chitosan nanoparticles in cisplatin sensitive and resistant lung cancer modelsSolid dispersions as strategy to improve oral bioavailability of poor water soluble drugs.A Mouse Intra-Intestinal Infusion Model and its Application to the Study of Nanoparticle Distribution.Nanoparticle-based drug delivery to improve the efficacy of antiretroviral therapy in the central nervous systemChitosan formulations as carriers for therapeutic proteins.Nanocarriers for pulmonary administration of peptides and therapeutic proteins.Mucoadhesive nanosystems for vaginal microbicide development: friend or foe?Mucoadhesive nanomedicines: characterization and modulation of mucoadhesion at the nanoscale.Models to predict intestinal absorption of therapeutic peptides and proteins.Cell-based in vitro models for predicting drug permeability.Novel non-invasive methods of insulin delivery.The importance of antimicrobial peptides and their potential for therapeutic use in ophthalmology.Smart stimuli sensitive nanogels in cancer drug delivery and imaging: a review.Drug-delivery systems of green tea catechins for improved stability and bioavailability.Nanotechnology and pulmonary delivery to overcome resistance in infectious diseases.An evaluation of the latest in vitro tools for drug metabolism studies.Quality by design: discussing and assessing the solid dispersions risk.Non-Small Cell Lung Carcinoma: An Overview on Targeted Therapy.Eradication of Helicobacter pylori: Past, present and future.
P50
Q24632900-76A38E94-58B6-4A81-865D-D81813AF2C91Q26741405-39E6A76B-CF4B-4B77-A5B5-6C0980FE2B74Q28087336-96B10620-13C9-41EF-A19D-452D8F3049D6Q30379795-C475B844-8817-458E-A608-238B9DBED30CQ30380354-5ACF2249-1ED1-4EFA-B454-D321C41C6D6EQ30382546-E2A59371-AA46-4858-9AC9-D156B1140A9DQ30390835-D225A7CB-12D8-4E70-8CAA-40399BCE07F1Q31155956-6BF2B00E-79C4-4ED2-B04E-B0F892C4BA00Q33230716-450EE2E2-3621-4592-91E1-B4E038F540FDQ33364419-AD35CA16-1FD5-492F-93CE-89A224F2B912Q33428087-8ACE368B-843B-463A-9B0A-F67B641B4D98Q34293616-0A0B2B54-4514-4045-8528-29CA41873288Q34415605-FF7BF2DA-D1E3-456D-B8C3-E79A29EFEC5DQ35502502-0A999BE0-1A37-418D-99E4-C966C9BE6750Q35829126-705FB762-9252-4FA6-A767-F0D867CEBD02Q35908887-0894B275-445F-4D52-A8FC-D9C447BEA5BEQ36106482-45E84F5E-6D6E-483C-A35B-4C96F45FAFC3Q36132498-DFDFB199-8B76-4AC5-AFE5-52A8B4985766Q36247961-FCF5BEB2-21F4-4E6C-9100-811B5321E610Q36250024-659B3039-FD4C-4801-8CB4-AFB723DC7EE9Q37003811-A707021A-78F5-409D-9652-DE0457F97D3BQ37013417-726F47BF-331D-4558-B2DF-1B28F727D7BFQ37025634-DD667968-806E-45FC-81F2-C6EF75FFEEEBQ37448385-4AC00BC3-2F49-4ABE-9BA6-1E7E91FA22E6Q37698620-042FB0C5-7ADD-4D08-9C67-30FE2924DDB4Q37811020-2AABD83E-C2C6-4B25-856A-70DB91609324Q37823598-BE566FC1-CAF8-4456-88AB-0267C728765CQ37867083-9A36E44D-59D8-41C4-BCC8-46D2B0D99BE0Q37877717-8904AD25-C32F-4D11-A2CE-BB571BE297A8Q37935826-08C27C5B-7781-4F9E-9BE8-B92E030CE931Q37994260-6A60F2A1-A561-49F8-9977-0BA3F74CC226Q38055517-0DB83D5F-5A59-46D2-9F36-35732A7E6592Q38057425-A750227D-3C4B-4303-A060-75CA38ADC74CQ38089212-A4FDF4B6-6BC9-4CEB-BD4F-A4E31B7F8CCBQ38120003-070ECABD-96DA-4FEA-997E-A6D39F353719Q38128069-C8C97307-AFC0-4110-B66F-0705A1294FB0Q38160881-A35B331C-D565-4E04-BC47-0C3A82563A12Q38187202-0547317F-D088-4AFD-AAF9-9FB6862B1658Q38215918-3599F469-CEDF-4A9C-85D6-A652633780F4Q38223572-A5C7D3AF-D5C6-41F1-9255-7D29A9AED30F
P50
description
hulumtues
@sq
researcher
@en
ricercatore
@it
wetenschapper
@nl
հետազոտող
@hy
name
Bruno Sarmento
@ast
Bruno Sarmento
@en
Bruno Sarmento
@es
Bruno Sarmento
@nl
Bruno Sarmento
@sl
type
label
Bruno Sarmento
@ast
Bruno Sarmento
@en
Bruno Sarmento
@es
Bruno Sarmento
@nl
Bruno Sarmento
@sl
prefLabel
Bruno Sarmento
@ast
Bruno Sarmento
@en
Bruno Sarmento
@es
Bruno Sarmento
@nl
Bruno Sarmento
@sl
P214
P244
P1053
J-6265-2013
P106
P108
P1153
14014524100
57193110303
P21
P213
0000 0003 5611 6750
P214
P244
n2011183549
P31
P3829
P496
0000-0001-5763-7553
P735
P7859
lccn-n2011183549